BioRegenx, Inc.
BRGX
$0.01
$0.0013.92%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.54M | -18.93M | -19.24M | -20.17M | -23.05M |
| Total Depreciation and Amortization | 75.10K | 611.70K | 1.20M | 1.73M | 2.22M |
| Total Amortization of Deferred Charges | 2.30K | 43.50K | 25.10K | 39.90K | 49.60K |
| Total Other Non-Cash Items | 1.13M | 17.93M | 17.59M | 17.73M | 19.93M |
| Change in Net Operating Assets | 377.70K | 297.60K | 429.00K | 482.90K | 528.70K |
| Cash from Operations | 38.90K | -42.10K | -1.70K | -182.20K | -324.20K |
| Capital Expenditure | -9.10K | -6.00K | 0.00 | 0.00 | -189.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | 0.00 | 0.00 | 1.40K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -50.00K | -47.30K | -47.30K | 2.70K | 0.00 |
| Cash from Investing | -59.10K | -53.30K | -47.30K | 2.70K | -187.90K |
| Total Debt Issued | 147.50K | 149.00K | 88.30K | 190.40K | 490.40K |
| Total Debt Repaid | -114.40K | -78.80K | -42.40K | -41.20K | -48.20K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 33.10K | 70.30K | 45.90K | 149.20K | 442.20K |
| Foreign Exchange rate Adjustments | -2.10K | 1.90K | -7.90K | -200.00 | 2.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.90K | -23.20K | -11.00K | -30.60K | -67.00K |